Results
1
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
1 companies
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩394,500.00
7D
13.4%
1Y
-35.1%